Level Bio AB Statistics

Total Valuation

Level Bio AB has a market cap or net worth of SEK 23.26 million. The enterprise value is 21.79 million.

Market Cap	23.26M
Enterprise Value	21.79M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Level Bio AB has 68.40 million shares outstanding. The number of shares has increased by 4.79% in one year.

Current Share Class	68.40M
Shares Outstanding	68.40M
Shares Change (YoY)	+4.79%
Shares Change (QoQ)	-20.10%
Owned by Insiders (%)	16.23%
Owned by Institutions (%)	13.86%
Float	32.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.69
PB Ratio	49.69
P/TBV Ratio	363.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.59
EV / Sales	0.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.01

Current Ratio	1.01
Quick Ratio	0.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.07

Financial Efficiency

Return on equity (ROE) is -150.80% and return on invested capital (ROIC) is -261.93%.

Return on Equity (ROE)	-150.80%
Return on Assets (ROA)	-12.71%
Return on Invested Capital (ROIC)	-261.93%
Return on Capital Employed (ROCE)	-341.87%
Weighted Average Cost of Capital (WACC)	11.25%
Revenue Per Employee	3.35M
Profits Per Employee	-287,200
Employee Count	10
Asset Turnover	2.51
Inventory Turnover	4.16

Taxes

In the past 12 months, Level Bio AB has paid 58,000 in taxes.

Income Tax	58,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.37% in the last 52 weeks. The beta is 1.27, so Level Bio AB's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	-22.37%
50-Day Moving Average	0.34
200-Day Moving Average	0.34
Relative Strength Index (RSI)	51.72
Average Volume (20 Days)	85,195

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Level Bio AB had revenue of SEK 33.51 million and -2.87 million in losses.

Revenue	33.51M
Gross Profit	17.95M
Operating Income	-2.71M
Pretax Income	-2.81M
Net Income	-2.87M
EBITDA	-258,158
EBIT	-2.71M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 1.46 million in cash and n/a in debt, giving a net cash position of 1.46 million or 0.02 per share.

Cash & Cash Equivalents	1.46M
Total Debt	n/a
Net Cash	1.46M
Net Cash Per Share	0.02
Equity (Book Value)	468,000
Book Value Per Share	n/a
Working Capital	133,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-537,000
Capital Expenditures	n/a
Depreciation & Amortization	2.19M
Net Borrowing	585,000
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 53.58%, with operating and profit margins of -8.09% and -8.57%.

Gross Margin	53.58%
Operating Margin	-8.09%
Pretax Margin	-8.40%
Profit Margin	-8.57%
EBITDA Margin	-0.77%
EBIT Margin	-8.09%
FCF Margin	n/a

Dividends & Yields

Level Bio AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.79%
Shareholder Yield	-4.79%
Earnings Yield	-12.35%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2